Результаты поиска

Hemoglobin SS Nigerian Woman First Diagnosed at the Age of 52 years with Manifestation Mimicking Tuberculosis of the Spine.

Sickle cell anemia (SCA) is an inherited disorder of hemoglobin due to the presence of abnormal hemoglobin in a homozygous state. Manifestation is usually in infancy or early childhood due to gradual decrease in hemoglobin F level as age advances. Diagnosis in middle age is unusual. We present a woman who was diagnosed of SCA for the first time at middle age. The aim was to bring to the knowledge of physicians that patients with SCA can also present late so high index of suspicion is required to make diagnosis. A 52-year-old woman presented to orthopedic clinic with complaints of generalized b

Toxicology and carcinogenesis studies of sodium dichromate dihydrate (Cas No. 7789-12-0) in F344/N rats and B6C3F1 mice (drinking water studies).

UNLABELLED: Sodium dichromate dihydrate is one of a number of inorganic compounds containing hexavalent chromium (Cr VI) found in drinking water source supplies as a contaminant resulting from various industrial processes including electroplating operations, leather tanning, and textile manufacturing. Because of the lack of adequate experimental data on the toxicity and carcinogenicity of hexavalent chromium ingested orally and because hexavalent chromium has been found in drinking water source supplies, the California Congressional Delegation, the California Environmental Protection Agency, a

NTP Toxicology and Carcinogenesis Studies of Pentachlorophenol (CAS NO. 87-86-5) in F344/N Rats (Feed Studies).

Pentachlorophenol has been used as an herbicide, algicide, defoliant, wood preservative, germicide, fungicide, and molluscicide. Pentachlorophenol was nominated by the National Cancer Institute for carcinogenicity testing based on its widespread use as a wood preservative, potential for entering the environment (pentachlorophenol residues have been found worldwide in soil, water, and air samples; in food products; and in human and animal tissues and body fluids), and likelihood of bioaccumulation in the environment (pentachlorophenol is persistent in soil, having a half-life of up to 5 years).

Успешное лечение множественной миеломы SARS-CoV-2 Инфекция: Отчёт по делу.

С момента объявления болезни коронавируса 2019 (В тыс.COVID-19) Пандемия в конце 2019, COVID-19 по-прежнему является глобальной проблемой. Пожилые пациенты, страдающие гематологическими расстройствами, имеют иммунокомпромиссные заболевания и, таким образом, весьма восприимчивы к ним. COVID-19 инфекция и острый острый респираторный синдром (САРС), что создает значительные клинические проблемы. В настоящем докладе содержится описание диагноза и лечения пациента с множественной миеломой (ММ), который SARS-CoV-2 Мы собрали общую информацию о пациентах, клинические характеристики, лабораторные резу

Sciatica как нетипичное первоначальное представление множественной миеломы: отчет о деле.

ВЕРТЕБРАЛЬНОЕ участие в множественной миеломе является частой причиной заболеваемости и связано с сильной болью, деформацией позвоночника и неврологическим компромиссом. Несмотря на то, что боль в спине является широко распространенной особенностью, сицика в качестве первоначального проявления множественной миеломы является крайне редким явлением, особенно у пациентов, не имеющих истории травм или остеопоротических факторов риска. Признание таких нетипичных презентаций имеет решающее значение для своевременной диагностики и управления. ОПИСАНИЕ СЛУЧАИ: Мужчина среднего возраста без какой-либо

Совпадение в полном тексте источника
… /L | 119.0 | 150.0–400.0 Monocytes, % | 11.6 | 1.7–9.3 Lymphocytes, % | 41 | 20–35 Eosinophils, % | 5.30 | 1.0–4.0 Immature granulocytes, % | 6.2 | ≤3 Nucleated red blood cells, % | 2 | ≤0 Reticulocyte absolute count, ×10 9 /L | 15.40 | 50–100 Width of erythrocyte coefficient, % | 14.9 | 11.8–14.5 Basophils …

Management of Gaucher Disease Type 1 in a Resource-Limited Setting: A Pediatric Case Study.

This case report depicts the management of an 8-year-old male with Gaucher Disease Type 1, manifesting as massive splenomegaly, anemia, and skeletal involvement in a resource-constrained environment. Treated with splenectomy due to the absence of enzyme replacement therapy, it underscores the necessity for enhanced therapeutic access and comprehensive care.

Совпадение в полном тексте источника
… Test | Result | Unit | Reference range Total leukocyte count | 4100 | Cells/cumm | 4000–11,000 Neutrophils | 42 | % | 40–75 Lymphocytes | 52 | % | 20–45 Eosinophils | 2 | % | 1–6 Monocytes | 4 | % | 2–10 Basophils | 0 | % | 0–1 Hemoglobin | 8.7 | g/dL | 11–18 Platelets | 75,000 | Cells/cumm | 150,000 …

The management of type 2 inflammatory respiratory diseases: a Chinese expert consensus [2024].

BackgroundType 2 (T2) inflammatory respiratory diseases encompass a range of conditions characterized by inflammation affecting the airways and lung parenchyma, with their pathogenesis rooted in T2 inflammation. Biological treatments that mitigate T2 inflammation revolutionize the therapeutic landscape for these respiratory diseases. However, there are decision-making difficulties in terms of the target population, timing of initiation, and type selection for biological targeted therapy.MethodsSearch strategies were focused on relevant issues related to T2 inflammatory respiratory diseases fro

Совпадение в полном тексте источника
… These cytokines affect diverse cells, including eosinophils, basophils, mast cells, and epithelial cells, thereby facilitating the initiation of T2 inflammation ( 24 ). … Arch Bronconeumol 2022 ; 58 : 595 - 600 . 10.1016/j.arbres.2021.11.006 35312535 66 Pereira Santos MC Campos Melo A Caetano A Longitudinal study of the expression of FcεRI and IgE on basophils and dendritic cells in association with basophil function in two patients with severe allergic asthma treated …

A Rare Case of Oligosecretory Multiple Myeloma With Intracranial Plasmacytoma.

Multiple myeloma (MM) is a hematologic malignancy characterized by monoclonal plasma cell proliferation within the bone marrow. According to current International Myeloma Working Group (IMWG) criteria, true non-secretory multiple myeloma (NSMM) is defined by the absence of detectable monoclonal protein even on serum free light chain (FLC) assay, unlike oligosecretory multiple myeloma (OSMM), in which electrophoresis and immunofixation are negative but the FLC κ/λ ratio is pathological - making diagnosis particularly challenging by conventional techniques. The association of OSMM with an intrac

Парастеральный перикардиоцентис для метициллина-сопротивляющегося Стафилокока ауреуса Перикардита, скомпрометированного Абсцессом и Тампонадой.

Перикардит (MRSA) является редким заболеванием и характеризуется высокой заболеваемостью и смертностью. Резюме дела: A 70-year-old Женщина с прошлым медицинским прошлым множеством миэломы, фибрилляциями, циррозом и сердечной анемией с уменьшенной фракцией выброса, покрытой болью в груди и диспной. Бактеремия MRSA из зараженного центрального венозного порта привела к септическому шоку и переднему перикардному абсцессу, что вызвало сердечный тампонад. Срочный парастеральный перикардиоцентез был выполнен, при этом флюифицированные культуры были положительными для МРСА. Несмотря на разрешение тамп

Совпадение в полном тексте источника
… Total nucleated cells | 570,000 cells/μL Red blood cells | 4,566 cells/μL Cells counted | 100 Neutrophils (%) | 98 Lymphocytes (%) | 1 Monocytes/Macrophages (%) | 1 Eosinophils (%) | 0 Basophils (%) | 0 Bacterial culture | Moderate-growth methicillin-resistant Staphylococcus aureus (day 2 of 2) Acid-fast …

Effect of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan™, on Symptoms, Fatigue and Quality of Life in Patients with Ulcerative Colitis in a Randomized Single-Blinded Placebo Controlled Study.

BackgroundIngestion of AndoSan™, based on the mushroom Agaricus blazei Murill, has previously been shown to exhibit anti-inflammatory effects because of reduction of pro-inflammatory cytokines in healthy individuals and patients with ulcerative colitis. In this randomized single-blinded placebo controlled study we examined whether intake of AndoSan™ also resulted in clinical effects.Methods and findings50 patients with symptomatic ulcerative colitis were block-randomized and blinded for oral daily intake of AndoSan™ or placebo for the 21 days' experimental period. The patients reported scores

Совпадение в полном тексте источника
… The EDTA blood was each time (days 0, 14 and 21) analyzed for haemoglobin, haematocrite, mean cellular volume, mean cellular haemoglobin, reticulocytes, immature reticulocytes, leukocytes including a differential count of neutrophils, basophils, eosinophils, lymphocytes and monocytes, thrombocytes, C-reactive … Effect on General Blood Parameters The following blood samples were analyzed at visit 1 and 3: CRP, leukocytes, eosinophils, basophils, neutrophils, lymphocytes, monocytes, hemoglobin, haematocrite, mean cellular volume, mean cellular haemoglobin, immature reticulocytes, reticulocytes, thrombocytes, …

A distinct CAR-T cell phenotype mediates therapeutic response at limited doses.

Chimeric antigen receptor (CAR) T-cell therapies are typically administered at high doses to maximize durable clinical responses. However, manufacturing constraints can limit the production of sufficient cells to achieve the intended dose. Although some patients experience durable responses after receiving lower CAR-T cell doses, the mechanisms underlying efficacy at these limited cell numbers remain poorly understood. To address this, we performed deep phenotyping of anti-CD19 CAR-T cell products and their corresponding leukapheresis starting materials from a phase I/II dose-escalation trial.

Совпадение в полном тексте источника
… These cells encompassed various populations, including CD4 and CD8 T cell subsets, γδ T cells, NK-T cells, NK cell subpopulations, classical, intermediate, and non-classical monocytes, conventional and plasmacytoid dendritic cells (DCs), and eosinophil-basophils (Fig. 4A , Supplementary Fig. 6A ). … Conversely, the pre-manufacturing blood of low-dose non-responders was highly enriched in various myeloid populations, including classical and non-classical monocytes, conventional DCs, plasmacytoid DCs, and eosinophils/basophils (Fig. 4B, C ). …

Case Report: IgG multiple myeloma and chronic myeloid leukemia in a single patient.

A 58-year-old man presented with recurrence of chronic myeloid leukemia (CML) after complete molecular remission in the setting of non-compliance with imatinib. He was restarted on imatinib and was also noted to have IgG kappa monoclonal gammopathy of undetermined significance (MGUS). The patient re-achieved molecular remission after resumption of imatinib, but his MGUS progressed to smoldering myeloma and he was eventually diagnosed with multiple myeloma (MM) and initiated on treatment for MM with thalidomide, bortezomib and dexamethasone. He has responded well to treatment of the myeloma and

Совпадение в полном тексте источника
… Graphical trend of white blood cell (WBC) count, lymphocytes and basophils. Figure 4. Graphical trend of hemoglobin. Figure 5. Graphical trend of platelet count. Figure 6. Graphical trend of creatinine. …

Educational Case: Atypical presentation of primary hyperparathyroidism with brown tumor.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… 46 MCV (mean corpuscular volume) (μm 3 ) 82 80–100 RDW (red blood cell distribution width) (%) 15.1 11.7–15.4 Platelet count (/mm 3 ) 260,000 150,000–400,000 WBC (white blood cells) (/mm 3 ) 7000 4500–11,000 Neutrophils (%) 58 40–60 Lymphocytes (%) 31 20–40 Monocytes (%) 7 2–8 Eosinophils (%) 3 1–4 Basophils … (μm 3 ) | 82 | 80–100 RDW (red blood cell distribution width) (%) | 15.1 | 11.7–15.4 Platelet count (/mm 3 ) | 260,000 | 150,000–400,000 WBC (white blood cells) (/mm 3 ) | 7000 | 4500–11,000 Neutrophils (%) | 58 | 40–60 Lymphocytes (%) | 31 | 20–40 Monocytes (%) | 7 | 2–8 Eosinophils (%) | 3 | 1–4 Basophils …

Can hyperleukocytosis be caused by a non-hematologic condition? A 10-year retrospective tertiary-care center cohort study.

BACKGROUND: Hyperleukocytosis (HL) is defined as a white blood cell counts typically exceeding 100 G/L and is commonly associated with hematologic malignancies. Efforts to identify and characterize non-hematologic causes of HL have been limited and insufficiently addressed in the literature. METHODS: We conducted a retrospective analysis of adult patient records from 2013 to 2023, screened for cases of HL with a primary focus on the characterization of non-hematologic causes. RESULTS: Out of 878,967 adult patients, 375 patients had HL; 90 were excluded due to opting out of general consent, l

Leptomeningeal metastasis in a marginal zone lymphoma, presenting as a delirium: case report.

BACKGROUND: Hematologic malignancies can spread to the central nervous system (CNS), either as focal lesions or as leptomeningeal disease. Marginal zone lymphoma (MZL) is a low-grade non-Hodgkin lymphoma and generally presents as an indolent disease. This case report illustrates an unexpected diagnosis of leptomeningeal metastasis in an MZL, presenting as a delirium without B symptoms, pronounced hematologic progression or abnormalities on cerebral imaging. CASE PRESENTATION: An 80-year-old patient with a medical history of monoclonal B-cell lymphocytosis (MBL) with a clone indicative for an

Urgent considerations on renal immune-related adverse events in oncology practice.

In recent years, immune checkpoint inhibitors (ICIs) have emerged as a critical component of hematological malignancies and solid malignant tumors therapy. However, clinical practice has revealed that these agents may induce immune-related adverse events (irAEs). Notably, renal irAEs stands out as a significant clinical concern, frequently necessitating treatment discontinuation and thereby enabling tumor progression. Renal irAEs constitutes a critical consideration for patients with cancer complicated by chronic kidney disease (CKD). This review systematically examines the immunologic pathoge

Совпадение в полном тексте источника
… Activated hypersensitivity reactions: MS4A2 (membrane-spanning 4-domains subfamily A member 2), IL4 (interleukin-4), and CCL26 (C-C motif chemokine ligand 26)—genes known to be involved in allergic response pathways, including those linked to immunoglobulin E (IgE), mast cells, eosinophils, and basophils … It includes sequestered antigens, bacteria, PD-L1 expression on renal tubules, T cell activation, cytokine release, molecular mimicry, epitope spreading, complement pathways, autoantibodies, and hypersensitivity reactions mediated by mast cells, eosinophils, and basophils. …

Историческое развитие иммуноэндокринных концепций психических расстройств и их терапии.

Отношения между центральной нервной, иммунной и эндокринной системами являются предметом психиатрических исследований, особенно в области депрессии и шизофрения. У поля длинные предтечи. Наблюдаемые явления, связанные с этими отношениями, восходят к неолитической эпохе. Теории иммуноэндокринной системы в самом широком смысле записаны в древности. В 19th Крепелин и Вагнер-Джаурег сообщили о первых клинических наблюдениях у пациентов психиатрических учреждений. Von Bestow, Эддисон и Кушинг описали психические симптомы у пациентов, страдающих эндокринными заболеваниями. :: 20th откровение века с

Unmasking TRALI: a case report of multiple myeloma and transfusion-associated event.

INTRODUCTION AND IMPORTANCE: Transfusion-related acute lung injury (TRALI) is a relatively rare but severe respiratory complication that can occur following the transfusion of blood products. Despite its infrequent occurrence, TRALI is a leading cause of transfusion-related mortality, underscoring the need for rapid diagnosis and appropriate management. However, diagnosis remains challenging due to its clinical overlap with other causes of acute respiratory distress syndrome (ARDS). CASE PRESENTATION: This report describes the case of a 57-year-old woman with multiple myeloma (MM) who develop

Воздействие лирагулитида на инсулиновую аллергию у пациента с глюкокортикоидным диабетом и множественным склерозом.

Глюкокортикоидное применение может вызвать вторичный диабет или усугубить гипергликемию у пациентов с сахарным диабетом (DM). Лираглютид - это глюкагон. peptide-1 (В тыс.GLP-1) рецептор агонист, используемый для лечения пациентов с типом 2 диабет. В нескольких сообщениях лирагулитид упоминается в качестве средства лечения ДМ, вызванного стероидами (SIDM). Здесь мы сообщаем о пациенте с SIDM и множественным склерозом, для которого переход на лирагулитид в сочетании с метформиновой терапией повысил уровень глюкозы и улучшил симптомы инсулиновой аллергии. Лираглютид может быть полезен для лечения

Secondary myeloid neoplasms after CD19 CAR T therapy in patients with refractory/relapsed B-cell lymphoma: Case series and review of literature.

BACKGROUND: Several chimeric antigen receptor T cells (CAR T) targeting CD19 have induced profound and prolonged remission for refractory/relapsed (R/R) B-cell lymphoma. The risk of secondary malignancies, especially myeloid neoplasms, is of particular concern in the CAR T community, which still remains unclear. METHODS: Four patients with R/R B-cell lymphoma after CD19 CAR T therapy diagnosed with secondary myeloid neoplasms (SMN) from 2 hospitals in eastern China were presented, including 3 with myelodysplastic syndrome (MDS) and 1 with acute myeloid leukemia (AML). Using single-cell RNA se